+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contrast Agent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Contrast Agent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Contrast Agent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 96 Pages
  • September 2025
  • Region: Global
  • Prof Research
  • ID: 5645812
Description Jump to:
The contrast agent market is a critical segment of the medical imaging industry, providing chemical substances used to enhance the visibility of tissues and organs during diagnostic procedures like CT, MRI, X-ray, PET/SPECT, and ultrasound. Contrast agents improve image clarity by altering the density or signal intensity of targeted areas, aiding in the diagnosis of conditions such as cancer, cardiovascular diseases, and neurological disorders. The market is characterized by innovation in safer and more effective agents, a shift toward non-ionic and low-osmolar compounds, and growing demand for imaging due to rising disease prevalence. By 2025, the global contrast agent market is estimated to be valued between USD 4.5 billion and USD 6.5 billion, with a projected compound annual growth rate (CAGR) of 3.2% to 6.5% through 2030. Growth is driven by increasing diagnostic imaging procedures, advancements in imaging technologies, and expanding healthcare access in emerging markets, though safety concerns and regulatory scrutiny pose challenges. Contrast agents are classified based on imaging modalities: iodinated contrast agents for CT and X-ray, gadolinium- and manganese-based agents for MRI, microbubble agents for ultrasound, and specialized agents for PET/SPECT and photoacoustic imaging. Iodinated agents, particularly non-ionic organic compounds like iohexol and iodixanol, dominate due to their versatility in imaging multiple organs. Gadolinium-based agents enhance MRI by altering water proton relaxation rates, improving soft tissue contrast. Microbubble agents, used in ultrasound, enhance vascular and tissue imaging through acoustic scattering. The industry is shaped by R&D to develop safer agents with reduced toxicity, such as non-nephrotoxic iodinated agents and manganese-based alternatives to gadolinium. Patent expirations for major agents like Bayer’s Ultravist and Gadovist have led to generic competition, while regulatory scrutiny over gadolinium retention and iodinated agent side effects influences market dynamics. The market is supported by the rising prevalence of chronic diseases and advancements in imaging technologies.

Regional Market Trends

The contrast agent market varies across regions, driven by healthcare infrastructure, imaging procedure volumes, and regulatory environments.
  • North America: The United States leads with a CAGR of 2.8%-5.5%, driven by high imaging procedure volumes, advanced healthcare systems, and adoption of novel agents. Canada contributes with a focus on MRI and CT diagnostics.
  • Europe: Germany, France, and the United Kingdom are key markets, with a CAGR of 2.5%-5.0%. Growth is supported by robust healthcare systems and demand for safer agents, though regulatory restrictions on gadolinium limit expansion.
  • Asia-Pacific: China and Japan drive growth with a CAGR of 4.0%-7.5%. China’s expanding healthcare infrastructure and Japan’s advanced imaging technologies boost demand for iodinated and gadolinium-based agents. India shows potential due to increasing generics adoption.
  • Latin America: Brazil and Mexico have a CAGR of 3.0%-6.0%, driven by rising healthcare access and diagnostic imaging demand. Cost-effective generics support growth.
  • Middle East and Africa (MEA): The region, including Saudi Arabia and South Africa, has a CAGR of 3.5%-6.5%. Growth is driven by improving healthcare infrastructure, but limited access to advanced agents constrains potential.

Application Analysis

The contrast agent market is segmented by application and type, each with distinct growth trends.
  • CT: Dominated by iodinated agents, this application has a CAGR of 2.8%-5.5%, driven by high CT procedure volumes for diagnosing cardiovascular and oncological conditions.
  • MRI: Gadolinium- and manganese-based agents drive this segment, with a CAGR of 3.0%-6.0%. Demand for safer alternatives to gadolinium, like manganese-based agents, is rising.
  • X-Ray & Fluorescence: Primarily uses iodinated agents, with a CAGR of 2.5%-5.0%, supported by widespread use in general diagnostics.
  • PET/SPECT: This niche segment has a CAGR of 3.5%-6.5%, driven by specialized agents for oncology and neurology imaging.
  • Ultrasound: Microbubble agents drive this segment, with a CAGR of 4.0%-7.0%, supported by growing adoption in cardiovascular and liver imaging.

Type Analysis

  • Gadolinium-containing Contrast Agent: Used in MRI, with a CAGR of 2.5%-5.5%. Safety concerns drive demand for alternatives, but generics sustain growth.
  • Iodinated Contrast Agent: Dominant in CT and X-ray, with a CAGR of 2.8%-5.8%. Non-ionic agents like iodixanol lead due to improved safety.
  • Manganese-based Contrast Agent: A growing segment with a CAGR of 3.5%-6.8%, driven by its potential as a safer MRI alternative.
  • Photoacoustic Contrast Agent: A niche segment with a CAGR of 4.0%-7.5%, supported by emerging imaging technologies.
  • Microbubble Contrast Agent: Used in ultrasound, with a CAGR of 4.2%-7.2%, driven by advancements in cardiovascular imaging.
  • Others: Including novel agents, with a CAGR of 3.0%-6.5%, driven by innovation in PET/SPECT and fluorescence imaging.

Selected Company Profiles

  • Bayer: Markets Ultravist (iodinated) and Gadovist (gadolinium), generating USD 0.9-1.5 billion in 2024. Patent expirations drive generic competition, but Bayer’s global reach sustains leadership.
  • Bracco: A leader in iodinated and gadolinium-based agents, generating USD 1-2 billion in 2024, with a strong presence in Europe and North America.
  • GE Healthcare: Markets iodinated and gadolinium-based agents, focusing on integrated imaging solutions for CT and MRI.
  • Guerbet: Offers iodinated and gadolinium-based agents, with a focus on safety and innovation in Europe and Asia-Pacific.
  • Ascelia Pharma AB: Specializes in manganese-based agents, targeting safer MRI alternatives with growth potential.

Industry Value Chain Analysis

The contrast agent value chain begins with R&D, developing agents with improved safety and efficacy through chemical synthesis and clinical trials. Manufacturing involves producing APIs for iodinated and gadolinium-based agents or microbubbles for ultrasound, adhering to strict quality standards. Distribution leverages global supply chains, ensuring availability through hospitals and imaging centers. Marketing targets radiologists and healthcare providers, emphasizing diagnostic accuracy and safety.

Healthcare providers administer contrast agents during imaging procedures, with patient safety monitored through pharmacovigilance. The value chain is supported by regulatory approvals and reimbursement systems, with leading companies integrating R&D, manufacturing, and distribution to optimize efficiency.

Opportunities and Challenges

Opportunities:

  • Rising Imaging Demand: Increasing prevalence of chronic diseases drives demand for diagnostic imaging and contrast agents.
  • Safer Agents: Innovations in non-ionic iodinated and manganese-based agents address safety concerns, boosting adoption.
  • Emerging Markets: Expanding healthcare infrastructure in Asia-Pacific and Latin America offers growth potential.
  • Technological Advancements: Advances in imaging modalities like photoacoustic and ultrasound imaging support new agent development.

Challenges:

  • Safety Concerns: Risks of gadolinium retention and iodinated agent nephrotoxicity limit adoption and drive regulatory scrutiny.
  • Patent Expirations: Expirations for agents like Ultravist and Gadovist increase generic competition, pressuring revenues.
  • Pricing Pressures: Cost containment by payers limits profitability, particularly in Europe.
  • Regulatory Hurdles: Stringent approval processes for new agents increase development costs.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Contrast Agent Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Contrast Agent Market in North America (2020-2030)
8.1 Contrast Agent Market Size
8.2 Contrast Agent Market by End Use
8.3 Competition by Players/Suppliers
8.4 Contrast Agent Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Contrast Agent Market in South America (2020-2030)
9.1 Contrast Agent Market Size
9.2 Contrast Agent Market by End Use
9.3 Competition by Players/Suppliers
9.4 Contrast Agent Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Contrast Agent Market in Asia & Pacific (2020-2030)
10.1 Contrast Agent Market Size
10.2 Contrast Agent Market by End Use
10.3 Competition by Players/Suppliers
10.4 Contrast Agent Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Contrast Agent Market in Europe (2020-2030)
11.1 Contrast Agent Market Size
11.2 Contrast Agent Market by End Use
11.3 Competition by Players/Suppliers
11.4 Contrast Agent Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Contrast Agent Market in MEA (2020-2030)
12.1 Contrast Agent Market Size
12.2 Contrast Agent Market by End Use
12.3 Competition by Players/Suppliers
12.4 Contrast Agent Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Contrast Agent Market (2020-2025)
13.1 Contrast Agent Market Size
13.2 Contrast Agent Market by End Use
13.3 Competition by Players/Suppliers
13.4 Contrast Agent Market Size by Type
Chapter 14 Global Contrast Agent Market Forecast (2025-2030)
14.1 Contrast Agent Market Size Forecast
14.2 Contrast Agent Application Forecast
14.3 Competition by Players/Suppliers
14.4 Contrast Agent Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Bayer
15.1.1 Company Profile
15.1.2 Main Business and Contrast Agent Information
15.1.3 SWOT Analysis of Bayer
15.1.4 Bayer Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.2 Bracco
15.2.1 Company Profile
15.2.2 Main Business and Contrast Agent Information
15.2.3 SWOT Analysis of Bracco
15.2.4 Bracco Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.3 GE Healthcare
15.3.1 Company Profile
15.3.2 Main Business and Contrast Agent Information
15.3.3 SWOT Analysis of GE Healthcare
15.3.4 GE Healthcare Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.4 Guerbet
15.4.1 Company Profile
15.4.2 Main Business and Contrast Agent Information
15.4.3 SWOT Analysis of Guerbet
15.4.4 Guerbet Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.5 Ascelia Pharma AB
15.5.1 Company Profile
15.5.2 Main Business and Contrast Agent Information
15.5.3 SWOT Analysis of Ascelia Pharma AB
15.5.4 Ascelia Pharma AB Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.6 FUJIFILM
15.6.1 Company Profile
15.6.2 Main Business and Contrast Agent Information
15.6.3 SWOT Analysis of FUJIFILM
15.6.4 FUJIFILM Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.7 Jiangsu Hengrui Medicine Co. Ltd.
15.7.1 Company Profile
15.7.2 Main Business and Contrast Agent Information
15.7.3 SWOT Analysis of Jiangsu Hengrui Medicine Co. Ltd.
15.7.4 Jiangsu Hengrui Medicine Co. Ltd. Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.8 Yangzijiang Pharmaceutical Group
15.8.1 Company Profile
15.8.2 Main Business and Contrast Agent Information
15.8.3 SWOT Analysis of Yangzijiang Pharmaceutical Group
15.8.4 Yangzijiang Pharmaceutical Group Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.9 Beijing Beilu Pharmaceutical Co. Ltd.
15.9.1 Company Profile
15.9.2 Main Business and Contrast Agent Information
15.9.3 SWOT Analysis of Beijing Beilu Pharmaceutical Co. Ltd.
15.9.4 Beijing Beilu Pharmaceutical Co. Ltd. Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.10 iMAX Diagnostic Imaging
15.10.1 Company Profile
15.10.2 Main Business and Contrast Agent Information
15.10.3 SWOT Analysis of iMAX Diagnostic Imaging
15.10.4 iMAX Diagnostic Imaging Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
15.11 Sanochemia
15.11.1 Company Profile
15.11.2 Main Business and Contrast Agent Information
15.11.3 SWOT Analysis of Sanochemia
15.11.4 Sanochemia Contrast Agent Revenue, Gross Margin and Market Share (2020-2025)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Contrast Agent Report
Table Data Sources of Contrast Agent Report
Table Major Assumptions of Contrast Agent Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Contrast Agent Picture
Table Contrast Agent Classification
Table Contrast Agent Applications
Table Drivers of Contrast Agent Market
Table Restraints of Contrast Agent Market
Table Opportunities of Contrast Agent Market
Table Threats of Contrast Agent Market
Table COVID-19 Impact for Contrast Agent Market
Table Raw Materials Suppliers
Table Different Production Methods of Contrast Agent
Table Cost Structure Analysis of Contrast Agent
Table Key End Users
Table Latest News of Contrast Agent Market
Table Merger and Acquisition
Table Planned/Future Project of Contrast Agent Market
Table Policy of Contrast Agent Market
Table 2020-2030 North America Contrast Agent Market Size
Figure 2020-2030 North America Contrast Agent Market Size and CAGR
Table 2020-2030 North America Contrast Agent Market Size by Application
Table 2020-2025 North America Contrast Agent Key Players Revenue
Table 2020-2025 North America Contrast Agent Key Players Market Share
Table 2020-2030 North America Contrast Agent Market Size by Type
Table 2020-2030 United States Contrast Agent Market Size
Table 2020-2030 Canada Contrast Agent Market Size
Table 2020-2030 Mexico Contrast Agent Market Size
Table 2020-2030 South America Contrast Agent Market Size
Figure 2020-2030 South America Contrast Agent Market Size and CAGR
Table 2020-2030 South America Contrast Agent Market Size by Application
Table 2020-2025 South America Contrast Agent Key Players Revenue
Table 2020-2025 South America Contrast Agent Key Players Market Share
Table 2020-2030 South America Contrast Agent Market Size by Type
Table 2020-2030 Brazil Contrast Agent Market Size
Table 2020-2030 Argentina Contrast Agent Market Size
Table 2020-2030 Chile Contrast Agent Market Size
Table 2020-2030 Peru Contrast Agent Market Size
Table 2020-2030 Asia & Pacific Contrast Agent Market Size
Figure 2020-2030 Asia & Pacific Contrast Agent Market Size and CAGR
Table 2020-2030 Asia & Pacific Contrast Agent Market Size by Application
Table 2020-2025 Asia & Pacific Contrast Agent Key Players Revenue
Table 2020-2025 Asia & Pacific Contrast Agent Key Players Market Share
Table 2020-2030 Asia & Pacific Contrast Agent Market Size by Type
Table 2020-2030 China Contrast Agent Market Size
Table 2020-2030 India Contrast Agent Market Size
Table 2020-2030 Japan Contrast Agent Market Size
Table 2020-2030 South Korea Contrast Agent Market Size
Table 2020-2030 Southeast Asia Contrast Agent Market Size
Table 2020-2030 Australia Contrast Agent Market Size
Table 2020-2030 Europe Contrast Agent Market Size
Figure 2020-2030 Europe Contrast Agent Market Size and CAGR
Table 2020-2030 Europe Contrast Agent Market Size by Application
Table 2020-2025 Europe Contrast Agent Key Players Revenue
Table 2020-2025 Europe Contrast Agent Key Players Market Share
Table 2020-2030 Europe Contrast Agent Market Size by Type
Table 2020-2030 Germany Contrast Agent Market Size
Table 2020-2030 France Contrast Agent Market Size
Table 2020-2030 United Kingdom Contrast Agent Market Size
Table 2020-2030 Italy Contrast Agent Market Size
Table 2020-2030 Spain Contrast Agent Market Size
Table 2020-2030 Belgium Contrast Agent Market Size
Table 2020-2030 Netherlands Contrast Agent Market Size
Table 2020-2030 Austria Contrast Agent Market Size
Table 2020-2030 Poland Contrast Agent Market Size
Table 2020-2030 Russia Contrast Agent Market Size
Table 2020-2030 MEA Contrast Agent Market Size
Figure 2020-2030 MEA Contrast Agent Market Size and CAGR
Table 2020-2030 MEA Contrast Agent Market Size by Application
Table 2020-2025 MEA Contrast Agent Key Players Revenue
Table 2020-2025 MEA Contrast Agent Key Players Market Share
Table 2020-2030 MEA Contrast Agent Market Size by Type
Table 2020-2030 Egypt Contrast Agent Market Size
Table 2020-2030 Israel Contrast Agent Market Size
Table 2020-2030 South Africa Contrast Agent Market Size
Table 2020-2030 Gulf Cooperation Council Countries Contrast Agent Market Size
Table 2020-2030 Turkey Contrast Agent Market Size
Table 2020-2025 Global Contrast Agent Market Size by Region
Table 2020-2025 Global Contrast Agent Market Size Share by Region
Table 2020-2025 Global Contrast Agent Market Size by Application
Table 2020-2025 Global Contrast Agent Market Share by Application
Table 2020-2025 Global Contrast Agent Key Vendors Revenue
Figure 2020-2025 Global Contrast Agent Market Size and Growth Rate
Table 2020-2025 Global Contrast Agent Key Vendors Market Share
Table 2020-2025 Global Contrast Agent Market Size by Type
Table 2020-2025 Global Contrast Agent Market Share by Type
Table 2025-2030 Global Contrast Agent Market Size by Region
Table 2025-2030 Global Contrast Agent Market Size Share by Region
Table 2025-2030 Global Contrast Agent Market Size by Application
Table 2025-2030 Global Contrast Agent Market Share by Application
Table 2025-2030 Global Contrast Agent Key Vendors Revenue
Figure 2025-2030 Global Contrast Agent Market Size and Growth Rate
Table 2025-2030 Global Contrast Agent Key Vendors Market Share
Table 2025-2030 Global Contrast Agent Market Size by Type
Table 2025-2030 Contrast Agent Global Market Share by Type
Table Bayer Information
Table SWOT Analysis of Bayer
Table 2020-2025 Bayer Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Bayer Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Bayer Contrast Agent Market Share
Table Bracco Information
Table SWOT Analysis of Bracco
Table 2020-2025 Bracco Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Bracco Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Bracco Contrast Agent Market Share
Table GE Healthcare Information
Table SWOT Analysis of GE Healthcare
Table 2020-2025 GE Healthcare Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 GE Healthcare Contrast Agent Revenue and Growth Rate
Figure 2020-2025 GE Healthcare Contrast Agent Market Share
Table Guerbet Information
Table SWOT Analysis of Guerbet
Table 2020-2025 Guerbet Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Guerbet Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Guerbet Contrast Agent Market Share
Table Ascelia Pharma AB Information
Table SWOT Analysis of Ascelia Pharma AB
Table 2020-2025 Ascelia Pharma AB Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Ascelia Pharma AB Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Ascelia Pharma AB Contrast Agent Market Share
Table FUJIFILM Information
Table SWOT Analysis of FUJIFILM
Table 2020-2025 FUJIFILM Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 FUJIFILM Contrast Agent Revenue and Growth Rate
Figure 2020-2025 FUJIFILM Contrast Agent Market Share
Table Jiangsu Hengrui Medicine Co. Ltd. Information
Table SWOT Analysis of Jiangsu Hengrui Medicine Co. Ltd.
Table 2020-2025 Jiangsu Hengrui Medicine Co. Ltd. Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Jiangsu Hengrui Medicine Co. Ltd. Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Jiangsu Hengrui Medicine Co. Ltd. Contrast Agent Market Share
Table Yangzijiang Pharmaceutical Group Information
Table SWOT Analysis of Yangzijiang Pharmaceutical Group
Table 2020-2025 Yangzijiang Pharmaceutical Group Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Yangzijiang Pharmaceutical Group Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Yangzijiang Pharmaceutical Group Contrast Agent Market Share
Table Beijing Beilu Pharmaceutical Co. Ltd. Information
Table SWOT Analysis of Beijing Beilu Pharmaceutical Co. Ltd.
Table 2020-2025 Beijing Beilu Pharmaceutical Co. Ltd. Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Beijing Beilu Pharmaceutical Co. Ltd. Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Beijing Beilu Pharmaceutical Co. Ltd. Contrast Agent Market Share
Table iMAX Diagnostic Imaging Information
Table SWOT Analysis of iMAX Diagnostic Imaging
Table 2020-2025 iMAX Diagnostic Imaging Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 iMAX Diagnostic Imaging Contrast Agent Revenue and Growth Rate
Figure 2020-2025 iMAX Diagnostic Imaging Contrast Agent Market Share
Table Sanochemia Information
Table SWOT Analysis of Sanochemia
Table 2020-2025 Sanochemia Contrast Agent Revenue Gross Profit Margin
Figure 2020-2025 Sanochemia Contrast Agent Revenue and Growth Rate
Figure 2020-2025 Sanochemia Contrast Agent Market Share

Companies Mentioned

  • Bayer
  • Bracco
  • GE Healthcare
  • Guerbet
  • Ascelia Pharma AB
  • FUJIFILM
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Yangzijiang Pharmaceutical Group
  • Beijing Beilu Pharmaceutical Co. Ltd.
  • iMAX Diagnostic Imaging
  • Sanochemia

Related Topics

Related Reports

Contrast Media - Global Strategic Business Report - Product Image

Contrast Media - Global Strategic Business Report

  • Report
  • 513 Pages
  • Global
From
Contrast Media Global Market Report 2025 - Product Image

Contrast Media Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Contrast Media Market Report by Type, Modality, Application, Route of Administration, End User, and Region 2025-2033 - Product Image

Contrast Media Market Report by Type, Modality, Application, Route of Administration, End User, and Region 2025-2033

  • Report
  • 144 Pages
  • Global
From
Contrast Media Market - Global Forecast 2025-2032 - Product Image

Contrast Media Market - Global Forecast 2025-2032

  • Report
  • 185 Pages
  • Global
From
Contrast Media/Contrast Agent Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Contrast Media/Contrast Agent Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.